Related Experiment Video
Updated: Jun 24, 2026
10:00
High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Interferon and heart disease
1School of Nursing and Health Studies, Georgetown University, Washington, DC 20057, USA. angerioa@georgetown.edu
Critical Care Nursing Quarterly
|March 21, 2009
Insights
Interferon gamma plays a key role in atherosclerosis, a chronic inflammatory condition driving heart disease. Understanding this immune response is crucial for developing new treatments for cardiovascular disease.
Area of Science:
- Cardiovascular Science
- Immunology
- Inflammation Biology
Background:
- Heart disease remains the primary cause of death and illness in the US.
- Atherosclerosis, a major contributor to heart disease, is characterized by chronic inflammation.
- Multiple factors are implicated in the development of this inflammatory process.
Purpose of the Study:
- To review the specific role of interferon gamma in the pathogenesis of atherosclerosis.
- To explore the mechanisms by which interferon gamma influences chronic inflammation in the context of cardiovascular disease.
Main Methods:
- Literature review of existing research on interferon gamma and atherosclerosis.
- Analysis of studies investigating inflammatory pathways in cardiovascular disease.
- Synthesis of data on the molecular and cellular functions of interferon gamma in atherogenesis.
Main Results:
- Interferon gamma is identified as a significant mediator of chronic inflammation in atherosclerosis.
- Evidence suggests interferon gamma influences key processes in plaque development and progression.
- The review consolidates findings on interferon gamma's impact on immune cell function and inflammatory signaling in the arterial wall.
Conclusions:
- Interferon gamma is a critical cytokine in the inflammatory cascade of atherosclerosis.
- Targeting interferon gamma pathways presents a potential therapeutic strategy for heart disease.
- Further research is warranted to fully elucidate the therapeutic potential of modulating interferon gamma in cardiovascular conditions.
Abstract:
Heart disease is the leading cause of morbidity and mortality in the United States. Atherosclerosis is the major cause of heart disease. It is a chronic inflammatory response. Many factors contribute to this chronic inflammation. This review looks at the role of interferon gamma in atherosclerosis.
More Related Videos
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...